FR2657016B1 - Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida. - Google Patents

Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.

Info

Publication number
FR2657016B1
FR2657016B1 FR9000455A FR9000455A FR2657016B1 FR 2657016 B1 FR2657016 B1 FR 2657016B1 FR 9000455 A FR9000455 A FR 9000455A FR 9000455 A FR9000455 A FR 9000455A FR 2657016 B1 FR2657016 B1 FR 2657016B1
Authority
FR
France
Prior art keywords
virus
hiv
applications
detection
peptides derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9000455A
Other languages
English (en)
Other versions
FR2657016A1 (fr
Inventor
Martin Jacques
Adda Denis
Somme Gerard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clonatec SA
Original Assignee
Clonatec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clonatec SA filed Critical Clonatec SA
Priority to FR9000455A priority Critical patent/FR2657016B1/fr
Priority to AT91400049T priority patent/ATE164853T1/de
Priority to DE69129207T priority patent/DE69129207T2/de
Priority to EP91400049A priority patent/EP0438332B1/fr
Priority to JP3023657A priority patent/JP3020289B2/ja
Publication of FR2657016A1 publication Critical patent/FR2657016A1/fr
Priority to US08/116,252 priority patent/US5480966A/en
Application granted granted Critical
Publication of FR2657016B1 publication Critical patent/FR2657016B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
FR9000455A 1990-01-16 1990-01-16 Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida. Expired - Lifetime FR2657016B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9000455A FR2657016B1 (fr) 1990-01-16 1990-01-16 Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
AT91400049T ATE164853T1 (de) 1990-01-16 1991-01-11 Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
DE69129207T DE69129207T2 (de) 1990-01-16 1991-01-11 Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
EP91400049A EP0438332B1 (fr) 1990-01-16 1991-01-11 Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA
JP3023657A JP3020289B2 (ja) 1990-01-16 1991-01-16 Ｈｉｖウイルス類のエンベロープ糖タンパク質由来のペプチド、これらのウイルスによって起こる感染の検出とエイズ症に対する予防接種へのこれらペプチドの用途
US08/116,252 US5480966A (en) 1990-01-16 1993-09-02 Peptides derived from the envelope glycoprotein of HIV viruses, their applications to the detection of infection caused by these viruses and to the vaccination against AIDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9000455A FR2657016B1 (fr) 1990-01-16 1990-01-16 Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.

Publications (2)

Publication Number Publication Date
FR2657016A1 FR2657016A1 (fr) 1991-07-19
FR2657016B1 true FR2657016B1 (fr) 1995-08-25

Family

ID=9392819

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9000455A Expired - Lifetime FR2657016B1 (fr) 1990-01-16 1990-01-16 Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.

Country Status (1)

Country Link
FR (1) FR2657016B1 (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84182B (pt) * 1986-01-22 1989-09-14 Pasteur Institut Novo retrovirus susceptivel de provocar o sida, meios e processos para a sua deteccao "in vitro"
JP2948823B2 (ja) * 1987-01-16 1999-09-13 アンステイテユ・パストウール ヒト免疫不全レトロウィルス（ｈｉｖ）関連抗原性ペプチド、そのウィルス感染の検出及びワクチンへの使用
ATE108457T1 (de) * 1987-03-25 1994-07-15 Genetic Systems Corp Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies

Also Published As

Publication number Publication date
FR2657016A1 (fr) 1991-07-19

Similar Documents

Publication Publication Date Title
DE3787002D1 (de) Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen.
ZA964694B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
EP0269712A4 (fr) Peptides impliques dans la pathogenese d'une infection du type hiv.
LTIP1792A (en) Aids virus envelope proteins, process for their production and purification, recombinant insect baculo-virus, vaccine against aids virus, diagnostic composition avd method of detection
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
MX9205244A (es) Micelas modificadas de caseina.
ATE154808T1 (de) Peptide mit den immunologischen eigenschaften von hiv-2
ES2194029T3 (es) Variantes del virus hiv-2.
MX9101810A (es) Vacuna contra virus de anemia de polio y diagnostico
EP0631506A4 (fr) Vaccins comprenant les proteines d'enveloppe du virus de l'immunodeficience humaine de type 1 selectivement deglycosylees.
DE69433007D1 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus
ITMI913092A1 (it) Vaccino di poxvirus ricombinante del virus del morbillo
NO871862D0 (no) Fremgangsmaate for paavisning av aids-virusinfeksjon.
DK641787A (da) Virusvektor, der koder for et glycoprotein fra det virus, der er ansvarligt for aids, vaccine, der omfatter virusvektoren eller glycoproteinet, samt antistof mod glycoproteinet
FR2591227B1 (fr) Peptides capables d'inhiber les interactions entre les virus lav et les lymphocytes t4, produits qui en sont derives et leurs applications
DE68910577D1 (de) Mittel gegen den AIDS-Virus.
FR2657017B1 (fr) Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
FR2657016B1 (fr) Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
ZA89862B (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
OA09653A (en) Rubella peptides
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
FR2620030B1 (fr) Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
CA2057612A1 (fr) Peptides selectionnes de l'antigene specifique au groupe (gag) du virus de l'immunodeficience humaine (vih), sa preparation et son utilisation
DK0498905T3 (da) Tilpassede epitoper af human immundeficiensvirus kappeglycoprotein gp120
EP0513371A4 (en) Human parainfluenza virus type 4a fusion protein and gene which codes for the same

Legal Events

Date Code Title Description
ST Notification of lapse
RN Application for restoration
FC Decision of inpi director general to approve request for restoration
TP Transmission of property